January 4, 2022 –  Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food and Drug Administration (FDA) clearance for a novel medical algorithm that analyzes ECG data from implantable loop recorders (ILRs). The newly 510(k) cleared ILR ECG Analyzer is an algorithm based on artificial intelligence (AI).               

January 4, 2022 — The Omicron variant, as of Dec. 25, made up 58.6% of new COVID-19 infections in the U.S., according to the Centers for Disease Control and Prevention (CDC). This week, the U.S. also reported more than 98,000 people hospitalized from COVID. The seven-day average of new cases also reached its highest level ever reported in the U.S. with more than 480,000 new cases. 

Among the top stories from December 2021 was new ultrasound transducer technology introduction by Philips Healthcare and the use of cardiac MRI to assess myocarditis caused by COVID-19 vaccinations.

January 4, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of December 2021. This is based on the website’s 127,056 pageviews for the month.

1. Late-breaking Science Presentations at the AHA 2021 Meeting

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device for the removal of inferior vena cava (IVC) filters. The device is designed for patients who have an IVC filter, a small cage-like device inserted into the largest vein in the body to capture blood clots and prevent them from traveling to the lungs. The Philips CavaClear Laser Sheath is intended for the removal of tissue to facilitate detachment of an IVC filter during retrieval when previous methods of removal have failed.

January 4, 2022 —  The U.S. Food and Drug Administration (FDA) has cleared Novartis' inclisiran (Leqvio), the first  small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an initial dose and one at three months. The drug provides effective and sustained LDL-C reduction of up to 52% vs. placebo for certain people with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statin therapy.[1,2]

January 3, 2022 — The following is a list of the 2021 news stories from the European Society of Cardiology (ESC) releases that saw the most  media coverage worldwide. These include lifestyle stories and the latest science published in ESC journals and presented at ESC Congress. Heart failure was also a hot topic, including ESC Guidelines on heart failure management.

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets with a contraindication for any individuals with a history of thrombosis with thrombocytopenia following the Janssen COVID-19 vaccine or any other adenovirus-vectored COVID-19 vaccine.

The fact sheets now include updated information about the risk of thrombosis with thrombocytopenia syndrome (TTS) following vaccination. The updates Occurred December 14.

Wishing you a healthy and happy New Year from the DAIC team. Look for many exciting new changes to come in 2022!

The most popular videos in 2021 included the use of ECMO for COVID-19 patients, a demonstration of the Medis QFR angiography image derived FFR system, and the use of remote EP monitoring systems.

December 26, 2021 — Here is a list of the most popular videos on the DAIC website from the past year in 2021 based on reader pageviews. Browse more videos.

1. VIDEO: ECMO Hemodynamic Support Effective in Sickest COVID-19 Patients 12,000 — Interview with Ryan Barbaro, M.D

December 23, 2021 — An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH) has detected significant changes in the heart muscle tissue of people who died from Covid-19. Damage to lung tissue has been the research focus in this area for some time and has now been thoroughly investigated.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now